Medifast (MED) Net Cash Flow (2010 - 2026)

Medifast's Net Cash Flow history runs 17 years deep, the most recent figure standing at -$17.8 million for Q1 2026.

• Quarterly Net Cash Flow fell 2352.72% year-over-year to -$17.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$20.2 million (down 248.98% YoY) and the FY2025 annual result came in at -$1.6 million, up 54.23% from the prior year.
• Net Cash Flow was -$17.8 million for Q1 2026 at Medifast, down from -$10.2 million in the prior quarter.
• Across five years, Net Cash Flow topped out at $36.0 million in Q1 2023 and bottomed at -$57.1 million in Q2 2022.
• A 5-year average of -$1.9 million and a median of $3.0 million in 2024 frame the typical range for Net Cash Flow.
• Annual changes were most pronounced in 2023 — Net Cash Flow jumped 161.41% — and 2026, when it sank 2352.72%.
• Medifast's Net Cash Flow stood at $18.3 million in 2022, then sank by 198.75% to -$18.1 million in 2023, then tumbled by 34.59% to -$24.4 million in 2024, then surged by 58.05% to -$10.2 million in 2025, then sank by 73.79% to -$17.8 million in 2026.
• Business Quant data shows MED's Net Cash Flow at -$17.8 million in Q1 2026, -$10.2 million in Q4 2025, and -$2.2 million in Q3 2025.